MERIAL, the animal health division of Sanofi, announced Dec. 20 that Sanofi has entered into a binding agreement to acquire the animal health division of Dosch Pharmaceuticals Pvt. Ltd., based in India.
Merial said this gives it a market entry into India's "strategically important and growing animal health sector."
The agreement is subject to regulatory approval and is expected to be finalized sometime in the first half of 2013. Financial details were not disclosed.
Dosch, headquartered in Mumbai, India, was incorporated in 1992 and is a diversified pharmaceutical company that operates primarily through two divisions: animal health and exports.
The animal health division being acquired by Merial has more than 86 products under 50 brands for ruminants, poultry and companion animals. Products include an extensive range of animal health therapeutics and nutritional feed supplements.
"The acquisition of Dosch's animal health division will be a significant milestone for Merial and gives us a strategic platform for our development in the Indian market," Merial chief executive officer Jose Barella said. "We are convinced that the combination of Dosch's animal health brands and distribution strength, along with the robust new product pipelines from both Merial and Dosch, will strongly position Merial to rapidly become a major animal health player in India."
The animal health market in India is estimated to be worth more than 350 million euros (based on internal Merial sources) in 2012 and is experiencing annual double-digit growth. India is home to the world's largest herd of cattle and buffalo, second-largest herd of sheep and goats and fifth-largest population of poultry. India is also the world's largest milk producer.
Merial provides a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,600 people and operates in more than 150 countries worldwide. Its 2011 sales reached more than 2 billion euros.